Log in

Synergy CHC Stock Forecast, Price & News

-0.01 (-14.29 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $0.06
50-Day Range
MA: $0.06
52-Week Range
Now: $0.06
Volume500 shs
Average Volume19,460 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Synergy CHC Corp., a consumer health care company, markets and distributes various consumer branded products primarily in the health and wellness industry in North America. The company offers FOCUSfactor, a brain-health nutritional supplement that includes a proprietary blend of brain supporting vitamins, minerals, antioxidants, and other nutrients; Flat Tummy Tea, a two-step herbal detox tea that works to help speed metabolism, boost energy, and reduce bloating; and Hand MD, an anti-aging skincare line formulated for the hands. It also provides Neuragen, a topical product that works directly at the site of the pain as opposed to oral products; UrgentRx, a flavored powdered medication for immediate relief of every day ailments, such as allergy attacks, headaches, aches and pains, heartburn, and upset stomach; Sneaky Vaunt, a backless, strapless, stick on, and push up bra; The Queen Pegasus, a two step eyelash elixir kit for natural eyelashes; and Per-fekt Beauty line of cosmetics. Synergy CHC Corp. sells its products directly to wholesalers and distributors; and online through flattummyco.com, sneakyvaunt.com, thequeenpegasus.com, and perfektbeauty.com, as well as through retail distribution channels. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was founded in 2012 and is headquartered in Westbrook, Maine.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars

Industry, Sector and Symbol

Industry Medical Distribution
Current SymbolOTCMKTS:SNYR



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
-0.01 (-14.29 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SNYR News and Ratings via Email

Sign-up to receive the latest news and ratings for SNYR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Synergy CHC (OTCMKTS:SNYR) Frequently Asked Questions

How has Synergy CHC's stock been impacted by COVID-19 (Coronavirus)?

Synergy CHC's stock was trading at $0.0650 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SNYR stock has decreased by 7.7% and is now trading at $0.06.
View which stocks have been most impacted by COVID-19

Who are some of Synergy CHC's key competitors?

What other stocks do shareholders of Synergy CHC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synergy CHC investors own include Guardion Health Sciences (GHSI), True Leaf Medicine International (MJ), Hemp (HEMP) and Biopharmx (BPMX).

Who are Synergy CHC's key executives?

Synergy CHC's management team includes the following people:
  • Mr. Jack Ross, Chairman, CEO & CFO (Age 53)
  • Mr. Patrick S. McCullough, Pres (Age 54)
  • Ms. Jaime Fickett, Sr. VP of Fin. & Operations
  • Mr. Al Baumeler, Exec. VP of Sales & Marketing - Retail

What is Synergy CHC's stock symbol?

Synergy CHC trades on the OTCMKTS under the ticker symbol "SNYR."

How do I buy shares of Synergy CHC?

Shares of SNYR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Synergy CHC's stock price today?

One share of SNYR stock can currently be purchased for approximately $0.06.

What is Synergy CHC's official website?

The official website for Synergy CHC is www.synergychc.com.

How can I contact Synergy CHC?

The company can be reached via phone at 615-939-9004.

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.